Premium
Screening recipients of increased‐risk donor organs: a survey of transplant infectious diseases physician practices
Author(s) -
Theodoropoulos N.,
Ladner D.P.,
Ison M.G.
Publication year - 2013
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12121
Subject(s) - medicine , transplantation , organ transplantation , transmission (telecommunications) , infectious disease (medical specialty) , hepatitis b virus , hepatitis b , hepatitis c virus , hepatitis c , disease , family medicine , immunology , intensive care medicine , virus , electrical engineering , engineering
Background In 1994, the Public Health Service published guidelines to minimize the risk of human immunodeficiency virus ( HIV ) transmission and to monitor recipients following the transplantation of organs from increased‐risk donors. A 2007 survey revealed the post‐transplant surveillance of recipients of organs from increased‐risk donors ( ROIRD ) is variable. Methods An electronic survey was sent to transplant infectious diseases physicians at US solid organ transplant centers. Results A total of 126 surveys were sent to infectious diseases physicians, and we received 51 (40%) responses. We found that 22% of respondents obtain only verbal, 69% verbal and written, and 8% do not obtain any special consent from ROIRD , despite an Organ Procurement and Transplantation Network policy requiring such consent. Post‐solid organ transplantation serologies for HIV , hepatitis B virus ( HBV ), and hepatitis C virus ( HCV ) are performed by 6–8% of respondents in all recipients, by 69% of respondents in ROIRD only, and 25% of respondents do not perform them at all. Post‐transplant nucleic acid testing is carried out by 55–64% of respondents in ROIRD , by 0–2% in all recipients, and not performed by 35–43% of respondents. Conclusion Screening RIORD for HIV , HBV , and HCV has increased since 2007, but remains less than optimal and is incomplete when screening for disease transmission at many centers.